TWiV 872: COVID-19 clinical update #104 with Dr. Daniel Griffin

March 5, 2022

In COVID-19 clinical update #104, Daniel Griffin reviews effectiveness of mRNA vaccines among children, number of children affected by disease, accuracy of rapid antigen tests, CDC guidance for prevention strategies, monoclonal antibody effectiveness, predicting progression to severe respiratory failure from pneumonia, risk of long COVID after two vaccine doses, and peripheral neuropathy in long COVID.

Click arrow to play
Download TWiV 872 (52 MB .mp3, 43 min)
Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

3 comments on “TWiV 872: COVID-19 clinical update #104 with Dr. Daniel Griffin

  1. Michelle Mar 5, 2022

    6:45 – Prof. Vincent had a good question – triple vaccinated get what? This *is* a concern for those 70, 80, and 90-year olds. I believe the CDC defines advanced age as something like a comorbidity or at-risk. What do triple vaccinated 70 year olds get?

  2. Juliette Mar 5, 2022

    What happened to 26:46-28 minutes when you are about to speak critically about cdc new metric? It’s a terrible shame if this is intentionally cut. This is the place we come to think and discuss things critically.